Simon Mariella, Chang Richard C, Bali Deeksha S, Wong Lee-Jun, Peng Ying, Abdenur Jose E
Division of Metabolic Disorders, CHOC Children's Hospital, 1201 West La Vita, Orange, CA, 92868, USA.
JIMD Rep. 2014;14:29-35. doi: 10.1007/8904_2013_280. Epub 2013 Nov 23.
Intermittent hypoglycemia has been described in association with Alpers' syndrome, a disorder caused by mutations in the mitochondrial DNA polymerase gamma gene. In some patients hypoglycemia may define the initial disease presentation well before the onset of the classical Alpers' triad of psychomotor retardation, intractable seizures, and liver failure. Correlating with the genotype, POLG pathogenicity is a result of increased mitochondrial DNA mutability, and mitochondrial DNA depletion resulting in energy deficient states. Hypoglycemia therefore could be secondary to any metabolic pathway affected by ATP deficiency. Although it has been speculated that hypoglycemia is due to secondary fatty acid oxidation defects or abnormal gluconeogenesis, the exact underlying etiology is still unclear. Here we present detailed studies on carbohydrate metabolism in an Alpers' patient who presented initially exclusively with intermittent episodes of hypoglycemia and ketosis. Our results do not support a defect in gluconeogenesis or fatty acid oxidation as the cause of hypoglycemia. In contrast, studies performed on liver biopsy suggested abnormal glycogenolysis. This is shown via decreased activities of glycogen brancher and debrancher enzymes with normal glycogen structure and increased glycogen on histology of the liver specimen. To our knowledge, this is the first report documenting abnormalities in glycogen metabolism in a patient with Alpers' syndrome.
间歇性低血糖与阿尔珀斯综合征相关,该综合征是由线粒体DNA聚合酶γ基因突变引起的一种疾病。在一些患者中,低血糖可能在经典的阿尔珀斯三联征(精神运动发育迟缓、难治性癫痫和肝功能衰竭)出现之前就很好地定义了疾病的初始表现。与基因型相关,POLG致病性是线粒体DNA变异性增加以及线粒体DNA耗竭导致能量缺乏状态的结果。因此,低血糖可能继发于受ATP缺乏影响的任何代谢途径。尽管有人推测低血糖是由于继发性脂肪酸氧化缺陷或糖异生异常,但确切的潜在病因仍不清楚。在此,我们对一名最初仅表现为间歇性低血糖和酮症发作的阿尔珀斯患者的碳水化合物代谢进行了详细研究。我们的结果不支持糖异生或脂肪酸氧化缺陷是低血糖的原因。相反,肝脏活检研究提示糖原分解异常。这通过糖原分支酶和脱支酶活性降低得以体现,而糖原结构正常,肝脏标本组织学检查显示糖原增加。据我们所知,这是第一份记录阿尔珀斯综合征患者糖原代谢异常的报告。